Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.81
-0.44-2.17%
At close: -
$19.79
-0.02-0.10%
After Hours: May 23, 6:39 PM EDT
Comments
Loading...
Eton Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:ETON | Benzinga
Eton Pharmaceuticals Inc has a consensus price target of $24.25 based on the ratings of 4 analysts. The high is $33 issued by HC Wainwright & Co. on March 19, 2025. The low is $10 issued by HC Wainwright & Co. on December 11, 2023. The 3 most-recent analyst ratings were released by B. Riley Securities, Craig-Hallum, and Craig-Hallum on May 16, 2025, May 14, 2025, and March 19, 2025, respectively. With an average price target of $26.67 between B. Riley Securities, Craig-Hallum, and Craig-Hallum, there's an implied 34.75% upside for Eton Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B. Riley Securities
Craig-Hallum
HC Wainwright & Co.
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Eton Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2025 | Buy Now | 31.38% | B. Riley Securities | Madison El-Saadi50% | $24 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2025 | Buy Now | 41.49% | Craig-Hallum | Chase Knickerbocker62% | $26 → $28 | Maintains | Buy | Get Alert |
| 03/19/2025 | Buy Now | 31.38% | Craig-Hallum | Chase Knickerbocker62% | $23 → $26 | Maintains | Buy | Get Alert |
| 03/19/2025 | Buy Now | 21.27% | B. Riley Securities | Madison El-Saadi50% | $21 → $24 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2025 | Buy Now | 66.75% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
| 01/23/2025 | Buy Now | 66.75% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $17 → $33 | Maintains | Buy | Get Alert |
| 01/10/2025 | Buy Now | 6.11% | B. Riley Securities | Madison El-Saadi50% | → $21 | Initiates | → Buy | Get Alert |
| 01/08/2025 | Buy Now | -9.04% | Craig-Hallum | Chase Knickerbocker62% | $15 → $18 | Maintains | Buy | Get Alert |
| 01/06/2025 | Buy Now | -14.1% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $15 → $17 | Maintains | Buy | Get Alert |
| 11/26/2024 | Buy Now | -24.2% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $11 → $15 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | -44.42% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 10/28/2024 | Buy Now | -24.2% | Craig-Hallum | Chase Knickerbocker62% | $10 → $15 | Maintains | Buy | Get Alert |
| 10/04/2024 | Buy Now | -49.47% | Craig-Hallum | Chase Knickerbocker62% | $8 → $10 | Maintains | Buy | Get Alert |
| 10/04/2024 | Buy Now | -44.42% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $9 → $11 | Maintains | Buy | Get Alert |
| 09/04/2024 | Buy Now | -54.52% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $9 | Assumes | → Buy | Get Alert |
| 05/06/2024 | Buy Now | -59.58% | Craig-Hallum | Chase Knickerbocker62% | → $8 | Initiates | → Buy | Get Alert |
| 12/11/2023 | Buy Now | -49.47% | HC Wainwright & Co. | Raghuram Selvaraju43% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | -49.47% | HC Wainwright & Co. | Raghuram Selvaraju43% | $9 → $10 | Maintains | Buy | Get Alert |
| 07/03/2023 | Buy Now | -54.52% | HC Wainwright & Co. | Raghuram Selvaraju43% | $10 → $9 | Maintains | Buy | Get Alert |
| 03/21/2023 | Buy Now | -49.47% | HC Wainwright & Co. | Raghuram Selvaraju43% | → $10 | Reiterates | → Buy | Get Alert |
| 09/26/2022 | Buy Now | -49.47% | HC Wainwright & Co. | Raghuram Selvaraju43% | $9 → $10 | Maintains | Buy | Get Alert |
| 07/25/2022 | Buy Now | -54.52% | HC Wainwright & Co. | Raghuram Selvaraju43% | $11 → $9 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Eton Pharmaceuticals (ETON) stock?
The latest price target for Eton Pharmaceuticals (NASDAQ:ETON) was reported by B. Riley Securities on May 16, 2025. The analyst firm set a price target for $26.00 expecting ETON to rise to within 12 months (a possible 31.38% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eton Pharmaceuticals (ETON)?
The latest analyst rating for Eton Pharmaceuticals (NASDAQ:ETON) was provided by B. Riley Securities, and Eton Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Eton Pharmaceuticals (ETON)?
There is no last upgrade for Eton Pharmaceuticals
When was the last downgrade for Eton Pharmaceuticals (ETON)?
There is no last downgrade for Eton Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Eton Pharmaceuticals (ETON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eton Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eton Pharmaceuticals was filed on May 16, 2025 so you should expect the next rating to be made available sometime around May 16, 2026.
Is the Analyst Rating Eton Pharmaceuticals (ETON) correct?
While ratings are subjective and will change, the latest Eton Pharmaceuticals (ETON) rating was a reiterated with a price target of $24.00 to $26.00. The current price Eton Pharmaceuticals (ETON) is trading at is $19.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
